BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29968113)

  • 21. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
    Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
    Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
    Stoffels I; Dissemond J; Pöppel T; Schadendorf D; Klode J
    JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study.
    Ballardini B; Santoro L; Sangalli C; Gentilini O; Renne G; Lissidini G; Pagani GM; Toesca A; Blundo C; del Castillo A; Peradze N; Caldarella P; Veronesi P
    Eur J Surg Oncol; 2013 Dec; 39(12):1332-6. PubMed ID: 24184123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT/CT and a portable gamma-camera for image-guided laparoscopic sentinel node biopsy in testicular cancer.
    Brouwer OR; Valdés Olmos RA; Vermeeren L; Hoefnagel CA; Nieweg OE; Horenblas S
    J Nucl Med; 2011 Apr; 52(4):551-4. PubMed ID: 21421720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Real-Time Fluorescent Indocyanine Green and (99m)Tc-Nanocolloid Radiotracer Navigation in Sentinel Lymph Node Biopsy of Penile Cancer.
    Markuszewski M; Polom W; Cytawa W; Czapiewski P; Lass P; Matuszewski M
    Clin Genitourin Cancer; 2015 Dec; 13(6):574-80. PubMed ID: 26231913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-
    Meershoek P; van den Berg NS; Brouwer OR; Teertstra HJ; Lange CAH; Valdés-Olmos RA; van der Hiel B; Balm AJM; Klop WMC; van Leeuwen FWB
    J Nucl Med; 2019 Jun; 60(6):764-769. PubMed ID: 30504140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden.
    Torbrand C; Warnolf Å; Glombik D; Davidsson S; Carlsson J; Baseckas G; Håkansson U; Trägårdh E; Geijer H; Liedberg F; Kirrander P
    Eur Urol Oncol; 2022 Dec; 5(6):704-711. PubMed ID: 36272960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
    Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
    Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
    Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An innovative multimodality approach for sentinel node mapping and biopsy in head and neck malignancies.
    Borbón-Arce M; Brouwer OR; van den Berg NS; Mathéron H; Klop WM; Balm AJ; van Leeuwen FW; Valdés-Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):274-9. PubMed ID: 24842707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence guided surgery and tracer-dose, fact or fiction?
    KleinJan GH; Bunschoten A; van den Berg NS; Olmos RA; Klop WM; Horenblas S; van der Poel HG; Wester HJ; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1857-67. PubMed ID: 27020580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes.
    KleinJan GH; van Werkhoven E; van den Berg NS; Karakullukcu MB; Zijlmans HJMAA; van der Hage JA; van de Wiel BA; Buckle T; Klop WMC; Horenblas S; Valdés Olmos RA; van der Poel HG; van Leeuwen FWB
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1915-1925. PubMed ID: 29696442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ICG-
    Paredes P; Vidal-Sicart S; Campos F; Tapias A; Sánchez N; Martínez S; Carballo L; Pahisa J; Torné A; Ordi J; Carmona F; Lomeña F
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1853-1861. PubMed ID: 28492965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid.
    Stoffels I; Leyh J; Pöppel T; Schadendorf D; Klode J
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1631-1638. PubMed ID: 26025245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer.
    Schaafsma BE; Verbeek FP; Rietbergen DD; van der Hiel B; van der Vorst JR; Liefers GJ; Frangioni JV; van de Velde CJ; van Leeuwen FW; Vahrmeijer AL
    Br J Surg; 2013 Jul; 100(8):1037-44. PubMed ID: 23696463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The worse survival outcomes reported for melanoma patients having sentinel node biopsy after lymphoscintigraphy the previous day do not appear to be due to overnight migration of Tc99m-nanocolloid tracer.
    Chakera AH; la Cour Sibbesen E; Schoedt M; Hölmich LR; Zerahn B; Thompson JF
    Eur J Surg Oncol; 2021 Sep; 47(9):2450-2453. PubMed ID: 33775485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.
    Verbeek FP; Tummers QR; Rietbergen DD; Peters AA; Schaafsma BE; van de Velde CJ; Frangioni JV; van Leeuwen FW; Gaarenstroom KN; Vahrmeijer AL
    Int J Gynecol Cancer; 2015 Jul; 25(6):1086-93. PubMed ID: 25768079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review.
    Buda A; Elisei F; Arosio M; Dolci C; Signorelli M; Perego P; Giuliani D; Recalcati D; Cattoretti G; Milani R; Messa C
    Int J Gynecol Cancer; 2012 Jun; 22(5):830-5. PubMed ID: 22617479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.